← European Medicine Shortage Tracker · all medicines
Bevacizumab currently has availability issues reported in 2 European registers: Austria, Italy.
Shortage ATC — · also listed as: BEVACIZUMAB · data refreshed 7 August 2026
As of 7 August 2026, 2 of the 10 tracked registers list current availability issues for Bevacizumab, covering 6 affected product presentations. The longest-running open report was filed in Austria on 2021-03-31 and has now been open for about 65 months. Where agencies state a cause, unexpectedly high demand lead with 3 of the 5 stated-cause reports, followed by commercial decisions or discontinuation with 2. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇪🇺 EU-wide (EMA) | Resolved Zirabev (bevacizumab) | 2025-01-17 | — | Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | register ↗ |
| 🇦🇹 Austria | Shortage Zirabev 25 mg/ml Konzentrat zur Herstellung einer Infusionslösung | 2021-03-31 | — | — | register ↗ |
| 🇮🇹 Italy | Shortage AYBINTIO + 4 more productsAYBINTIO OYAVAS OYAVAS VEGZELMA | 2026-02-08 | — | Elevata richiesta Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
Every individual register entry for Bevacizumab in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | OYAVAS | Shortage | 2026-06-30 | — | Cessata commercializzazione temporanea |
| 🇮🇹 IT | VEGZELMA | Shortage | 2026-05-01 | — | Elevata richiesta |
| 🇮🇹 IT | OYAVAS | Shortage | 2026-03-31 | — | Cessata commercializzazione definitiva |
| 🇮🇹 IT | AYBINTIO | Shortage | 2026-02-21 | — | Elevata richiesta |
| 🇮🇹 IT | AYBINTIO | Shortage | 2026-02-08 | — | Elevata richiesta |
| 🇪🇺 EU | Zirabev (bevacizumab) | Resolved | 2025-01-17 | — | Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-C |
| 🇦🇹 AT | Zirabev 25 mg/ml Konzentrat zur Herstellung einer Infusionslösung | Shortage | 2021-03-31 | — |
Yes. As of 7 August 2026, availability issues are reported in: Austria, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
5 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Bevacizumab: BASG (Austria), EMA shortages catalogue (EU), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Bevacizumab — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bevacizumab/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Bevacizumab availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bevacizumab/">Bevacizumab shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>